Assessing the efficacy and safety of Yinqiao powder-maxing Ganshi decoction in the treatment of the major symptoms of mild and moderate COVID-19 by telemedicine-study protocol for a randomized, double-blind, placebo-controlled trial
Background: The Coronavirus disease 2019 (COVID-19) is the largest global epidemic in recent time. Chinese medicine has been recognized by the World Health Organization as an effective treatment for COVID-19, but there is still a lack of high-quality randomized, double-blind trials using placebo as...
Saved in:
Main Authors: | Chi Him Sum (Author), Tong Wendy Li (Author), Hongwei Zhang (Author), Hing Yu Hung (Author), Ben Yuk Fai Fong (Author), Wai Ling Lin (Author), Tak Yee Chow (Author), Ka Chun Leung (Author), Cho Wing Lo (Author), Chon Pin Chia (Author), Kam Leung Chan (Author), Zhi-xiu Lin (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The efficacy and safety of Yupingfeng Powder with variation in the treatment of allergic rhinitis: Study protocol for a randomized, double-blind, placebo-controlled trial
by: Pui Kuan Cheong, et al.
Published: (2022) -
COVID-19 - A Tale of Two Cities: Seattle and Vancouver
by: Ben Yuk Fai Fong, et al.
Published: (2020) -
Review of Public Private Partnership in the Health Care in Hong Kong
by: Cynthia Lau, et al.
Published: (2021) -
Corrigendum: A Chinese medicine formula (Bushen Huoxue Tongluo) for the treatment of chronic subjective tinnitus: a study protocol for a pilot, assessor-blinded, randomized clinical trial
by: Hong Wei Zhang, et al.
Published: (2023) -
A Chinese Medicine Formula (Bushen Huoxue Tongluo) for the Treatment of Chronic Subjective Tinnitus: A Study Protocol for a Pilot, Assessor-Blinded, Randomized Clinical Trial
by: Hong Wei Zhang, et al.
Published: (2022)